{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:10:27Z","timestamp":1778739027113,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-026-07930-5","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T17:58:23Z","timestamp":1768499903000},"page":"1091-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and effectiveness of rituximab therapy in Sj\u00f6gren\u2019s disease: a PORTRESS \u2013 the Portuguese registry of Sj\u00f6gren\u2019s disease-based study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3239-2400","authenticated-orcid":false,"given":"Carla","family":"Campinho Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pereira da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Matias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Catarina","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Marques-Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Fernandes Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edgia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cla\u00fadia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duarte","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Rua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasco C.","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Leite Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"11","key":"7930_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7930_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R (2024) Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(3):158\u2013169. https:\/\/doi.org\/10.1038\/s41584-023-01057-6","journal-title":"Nat Rev Rheumatol"},{"key":"7930_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731122","volume":"12","author":"YH Chen","year":"2021","unstructured":"Chen YH, Wang XY, Jin X, Yang Z, Xu J (2021) Rituximab therapy for primary Sj\u00f6gren\u2019s syndrome. Front Pharmacol 12:731122. https:\/\/doi.org\/10.3389\/fphar.2021.731122","journal-title":"Front Pharmacol"},{"issue":"5","key":"7930_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, Gattamelata A, Maset M, Modesti M, Tavoni A, De Vita S, Gerli R, Valesini G, Bombardieri S (2014) Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 53(5):839\u2013844. https:\/\/doi.org\/10.1093\/rheumatology\/ket427","journal-title":"Rheumatology (Oxford)"},{"key":"7930_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae035","author":"M Bandeira","year":"2024","unstructured":"Bandeira M, Silv\u00e9rio-Ant\u00f3nio M, Khmelinskii N, Fonseca JE, Rom\u00e3o VC (2024) Beyond sicca: high prevalence and predictors of baseline and worsening systemic involvement in patients with Sj\u00f6gren\u2019s disease. Rheumatol Adv Pract. https:\/\/doi.org\/10.1093\/rap\/rkae035","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"7930_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X (2018) B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 14(3):133\u2013145. https:\/\/doi.org\/10.1038\/nrrheum.2018.1","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7930_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sis\u00f3-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X (2020) EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216114","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7930_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/rheumatology\/keae152","volume":"64","author":"EJ Price","year":"2025","unstructured":"Price EJ, Benjamin S, Bombardieri M, Bowman S, Carty S, Ciurtin C, Crampton B, Dawson A, Fisher BA, Giles I, Glennon P, Gupta M, Hackett KL, Larkin G, Ng WF, Ramanan AV, Rassam S, Rauz S, Smith G, Sutcliffe N, Tappuni A, Walsh SB (2025) British Society for Rheumatology guideline on management of adult and juvenile onset Sj\u00f6gren disease. Rheumatology (Oxford) 64(2):409\u2013439. https:\/\/doi.org\/10.1093\/rheumatology\/keae152","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7930_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/m13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Pu\u00e9chal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A (2014) Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial. Ann Intern Med 160(4):233\u2013242. https:\/\/doi.org\/10.7326\/m13-1085","journal-title":"Ann Intern Med"},{"issue":"7","key":"7930_CR10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.40093","volume":"69","author":"SJ Bowman","year":"2017","unstructured":"Bowman SJ, Everett CC, O\u2019Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M (2017) Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 69(7):1440\u20131450. https:\/\/doi.org\/10.1002\/art.40093","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"7930_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","volume":"72","author":"JE Gottenberg","year":"2013","unstructured":"Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X (2013) Efficacy of rituximab in systemic manifestations of primary Sjogren\u2019s syndrome: results in 78 patients of the autoimmune and rituximab registry. Ann Rheum Dis 72(6):1026\u20131031. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202293","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7930_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3899\/jrheum.210441","volume":"49","author":"O Berardicurti","year":"2022","unstructured":"Berardicurti O, Pavlych V, Cola ID, Ruscitti P, Di Benedetto P, Navarini L, Marino A, Cipriani P, Giacomelli R (2022) Long-term safety of rituximab in primary sj\u00f6gren syndrome: the experience of a single center. J Rheumatol 49(2):171\u2013175. https:\/\/doi.org\/10.3899\/jrheum.210441","journal-title":"J Rheumatol"},{"issue":"2","key":"7930_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, D\u00f6rner T, Tzioufas A, Gottenberg JE, Laqu\u00e9 R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zer\u00f3n P, Vitali C, Mariette X (2016) Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382\u2013389. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"key":"7930_CR14","doi-asserted-by":"publisher","unstructured":"Bandeira M, Silv\u00e9rio-Ant\u00f3nio M, Costa R, Lopes A, Santos F, Pereira P, Raimundo D, Cunha A, Oliveira C, Duarte A, Dias J, Santos M, Gon\u00e7alves M, Moniz A, Maduro A, Lu\u00eds M, Valido A, Oliveira M, Brites L, Tenazinha C, Vieira A, Khmelinskii N, Barcelos B, Fonseca J, Rom\u00e3o VC (2025) PORTRESS Reuma.pt Task Force. PORTRESS \u2013 the PORTuguese Reuma.pt registry for Sj\u00f6gren\u2019S disease. ARP Rheumatol 4(3):183\u2013193. https:\/\/doi.org\/10.63032\/BKRA9238","DOI":"10.63032\/BKRA9238"},{"issue":"8","key":"7930_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/acr2.11466","volume":"4","author":"S Pepple","year":"2022","unstructured":"Pepple S, Arnold J, Vital EM, Rawstron AC, Pease CT, Dass S, Emery P, Yusof MY (2022) Predicting sustained clinical response to rituximab in moderate to severe systemic manifestations of primary Sj\u00f6gren syndrome. ACR Open Rheumatol 4(8):689\u2013699. https:\/\/doi.org\/10.1002\/acr2.11466","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"7930_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/ar4359","volume":"15","author":"F Carubbi","year":"2013","unstructured":"Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R (2013) Efficacy and safety of rituximab treatment in early primary Sj\u00f6gren\u2019s syndrome: a prospective, multi-center, follow-up study. Arthritis Res Ther 15(5):R172. https:\/\/doi.org\/10.1186\/ar4359","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"7930_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/annrheumdis-2011-200460","volume":"71","author":"PM Meiners","year":"2012","unstructured":"Meiners PM, Arends S, Brouwer E, Spijkervet FK, Vissink A, Bootsma H (2012) Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sj\u00f6gren\u2019s syndrome treated with rituximab. Ann Rheum Dis 71(8):1297\u20131302. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200460","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7930_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4078\/jrd.2024.0149","volume":"32","author":"M Shahdadian","year":"2025","unstructured":"Shahdadian M, Saghiri MA, Capitle E (2025) Efficacy of early rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. J Rheum Dis 32(3):211\u2013224. https:\/\/doi.org\/10.4078\/jrd.2024.0149","journal-title":"J Rheum Dis"},{"key":"7930_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561214","volume":"16","author":"X Zheng","year":"2025","unstructured":"Zheng X, Di J, Chen X, Li F, Liu Y, Cao J, Ning X, Wei L, Zheng G (2025) Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sj\u00f6gren\u2019s syndrome. Front Immunol 16:1561214. https:\/\/doi.org\/10.3389\/fimmu.2025.1561214","journal-title":"Front Immunol"},{"issue":"4","key":"7930_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62(4):960\u2013968. https:\/\/doi.org\/10.1002\/art.27314","journal-title":"Arthritis Rheum"},{"issue":"4","key":"7930_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/art.37850","volume":"65","author":"EW St Clair","year":"2013","unstructured":"St Clair EW, Levesque MC, Prak ET, Vivino FB, Alappatt CJ, Spychala ME, Wedgwood J, McNamara J, Sivils KL, Fisher L, Cohen P (2013) Rituximab therapy for primary Sj\u00f6gren\u2019s syndrome: an open-label clinical trial and mechanistic analysis. Arthritis Rheum 65(4):1097\u20131106. https:\/\/doi.org\/10.1002\/art.37850","journal-title":"Arthritis Rheum"},{"issue":"2","key":"7930_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/art.22536","volume":"57","author":"V Devauchelle-Pensec","year":"2007","unstructured":"Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S, Roudaut A, Jamin C, Renaudineau Y, Rou\u00e9 IQ, Cochener B, Youinou P, Saraux A (2007) Improvement of Sj\u00f6gren\u2019s syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 57(2):310\u2013317. https:\/\/doi.org\/10.1002\/art.22536","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07930-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07930-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07930-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:03:05Z","timestamp":1769763785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07930-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7930"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07930-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}